Muaña, Eunice Zyra Mae R.

HRN: 17-56-40  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/12/2025
08/13/2025
PO
500mg
Q8
Cs
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: